Sudeep Pharma Limited operates in the pharmaceutical excipients, food-grade minerals, and speciality nutrition ingredients segment. The company’s portfolio spans various mineral-based products that meet the requirements of the pharmaceutical, food, and nutrition industries. Its operations are supported by research-led capabilities and compliant manufacturing processes, which enable it to serve a diverse set of customers across several global markets. With multiple product categories, including pharmaceutical and nutrition solutions, speciality ingredients, and triturates, the company maintains a stable presence within its sector.
To apply for the Sudeep Pharma IPO, an investor can log in to an investment or trading platform that offers IPO application services and locate the IPO within the platform’s IPO section. After selecting the issue, the investor can fill out the application form, select the quantity as per the applicable lot size, and complete the payment process via an available method, such as UPI, which blocks the required amount. Once the details are submitted, the investor can monitor the platform for updates on the application status.
For more details, visit the Sudeep Pharma Limited IPO page.
Sudeep Pharma Limited IPO Details and Objectives
Details
| Information
|
IPO Date
| November 21, 2025 to November 25, 2025
|
Issue Size
| 1,50,92,750 shares (aggregating up to ₹895.00 Cr)
|
Price Band
| ₹563 to ₹593 per share
|
Lot Size
| 25 shares
|
Listing At
| BSE NSE
|
Purpose of the IPO
Timeline of Sudeep Pharma Limited IPO
Event
| Date
|
|---|
IPO Open Date
| Fri, Nov 21, 2025
|
IPO Close Date
| Tue, Nov 25, 2025
|
Tentative Allotment
| Wed, Nov 26, 2025
|
Initiation of Refunds
| Thu, Nov 27, 2025
|
Credit of Shares to Demat
| Thu, Nov 27, 2025
|
Tentative Listing Date
| Fri, Nov 28, 2025
|
Cut-off time for UPI mandate confirmation
| 5 PM on Tue, Nov 25, 2025
|
Pricing & Lot Size of Sudeep Pharma Limited IPO
Price Band for the IPO
Minimum Lot Size and Application Details
Application
| Lots
| Shares
| Amount
|
Retail (Min)
| 1
| 25
| ₹14,825
|
Retail (Max)
| 13
| 325
| ₹1,92,725
|
S-HNI (Min)
| 14
| 350
| ₹2,07,550
|
S-HNI (Max)
| 67
| 1,675
| ₹9,93,275
|
B-HNI (Min)
| 68
| 1,700
| ₹10,08,100
|
Sudeep Pharma Limited IPO Application Process
The Sudeep Pharma Limited IPO application process can be completed online through your trading platform. Below is a step-by-step guide to applying for the IPO:
Step 1: Login to Your Trading Platform
Access your trading account using the broker's app or website.
Step 2: Navigate to the IPO Section
Go to the IPO section to view active IPO listings.
Step 3: Select the Open IPO and Click Apply
Locate Sudeep Pharma Limited IPO in the list of available IPOs and click the ‘Apply’ button.
Step 4: Enter the Quantity of Shares You Wish to Apply For
Specify the number of shares (minimum lot size: 25 shares) within the price band of ₹563 to ₹593 per share.
Step 5: Provide Your UPI ID
Enter your UPI ID for payment authorization and ensure sufficient funds in your bank account.
Step 6: Confirm the Application
Review your application details and confirm the UPI mandate before 5 PM on the last application day.
Step 7: Complete the Process and Wait for Allotment
Submit the application and monitor the allotment status to check if shares have been allocated to you.
Financial Health and Performance
Key Financial Metrics
Total Assets: Grew from ₹420.11 crore in FY24 to ₹922.26 crore as of June 2025.
Total income: Reached ₹130.08 crore in FY25.
Profit After Tax (PAT): Stood at ₹31.27 crore for June 2025.
Net Worth: Recorded at ₹688.32 crore in FY25.
Reserves and Surplus: Recorded at ₹668.52 crore (June 2025), growing steadily over the years.
EBITDA: Stood at ₹48.57 crore in June 2025.
Recent Performance and Growth Prospects
The company has shown consistent expansion in its asset base, reflecting the scale of its ongoing operations and investments.
Its income level has displayed steady progress, supported by business activities across its operating segments.
Profitability has remained stable, indicating sustained performance during the recent period.
The organisation’s financial position appears supported by an increasing net worth, demonstrating internal strengthening over time.
Reserves have continued to grow, suggesting careful financial management and retained earnings.
Operating efficiency has been reinforced by stable operational profits, contributing to the company’s overall financial outlook.
Investment Risks and Opportunities
Potential Risks of Investing in the IPO
The company operates in a sector influenced by regulatory requirements, and any changes in compliance guidelines may affect its operations.
Dependence on raw materials and market-driven demand conditions may introduce uncertainties that could influence future performance.
Opportunities and Growth Potential
The company’s diversified portfolio across pharmaceutical, food, and nutrition segments creates scope for expansion within multiple markets.
Its research-driven approach and compliant manufacturing facilities may support ongoing development of new products and operational strengthening.
Key Performance Indicator (KPI)
KPI
| Values
|
Debt/Equity
| 0.20
|
RoNW
| 27.88%
|
PAT Margin
| 27.63%
|
EBITDA Margin
| 39.70%
|
Price to Book Value
| 12.93
|
Market Capitalization
| ₹6,697.85 Cr.
|
Sudeep Pharma Limited IPO Registrar & Lead Managers
Registrar
| Lead Manager(s)
|
|---|
MUFG Intime India Pvt.Ltd.
| ICICI Securities Ltd.
|
Company Address of Sudeep Pharma Limited Ltd.
Sudeep Pharma Ltd. 129/1/A, GIDC Estate, Nandesari, Vadodara, Gujarat, 391340
Phone: +91 265 284 0656
Email: cs.sudeep@sudeepgroup.com
Website: https://www.sudeeppharma.com/
Conclusion
Sudeep Pharma Limited’s IPO offers information about the company’s operations, financial position, and business activities across the pharmaceutical excipients and mineral-based ingredients segment. The details shared in the issue documents outline its focus areas, manufacturing capabilities, and presence across domestic and global markets. Investors can review these aspects to understand the organisation’s background and key functions before proceeding further.
The application process is structured to guide investors through each step, from accessing the IPO section to confirming the payment mandate. By following the instructions provided through their respective trading platforms, applicants can complete the procedure and track subsequent updates. This approach allows investors to assess the IPO based on the available disclosures and timelines.
Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your Sudeep Pharma IPO allotment status.